Lipella Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch LIPO and buy or sell other stocks, ETFs, and their options commission-free!

About LIPO

Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent.

CEO

Jonathan Kaufman

CEOJonathan Kaufman

Employees

Employees7

Headquarters

Pittsburgh, Pennsylvania

HeadquartersPittsburgh, Pennsylvania

Founded

2005

Founded2005

Employees

Employees7

LIPO Key Statistics

Market cap

10.54M

Market cap10.54M

Price-Earnings ratio

-3.97

Price-Earnings ratio-3.97

Dividend yield

—

Dividend yield—

Average volume

434.56K

Average volume434.56K

High today

—

High today—

Low today

—

Low today—

Open price

$1.75

Open price$1.75

Volume

0.00

Volume0.00

52 Week high

$1.50

52 Week high$1.50

52 Week low

$0.2804

52 Week low$0.2804

People also own

Based on the portfolios of people who own LIPO. This list is generated using Robinhood data, and it’s not a recommendation.